Published in Recent Results Cancer Res on January 01, 1988
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol (1998) 1.74
The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. Cancer Res (1985) 1.33
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin. Anticancer Res (1999) 1.24
Renal complications in acute leukemias. Haematologica (1998) 1.23
Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch Dermatol Res (1980) 1.22
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer. Ann Oncol (2000) 1.17
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Onkologie (2003) 1.17
Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer (2001) 1.13
Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol (2001) 1.00
Circulating nucleosomes in serum. Ann N Y Acad Sci (2001) 0.99
What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol (1985) 0.99
Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure. Pediatr Hematol Oncol (1996) 0.96
Apoptosis in serum of patients with solid tumours. Anticancer Res (1999) 0.94
Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut (1992) 0.93
Split dose recovery of a mouse tumour and its stroma during fractionated irradiation. Br J Radiol (1982) 0.91
Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol (1991) 0.91
Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas. Anticancer Res (1999) 0.90
Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours. Eur J Cancer (1991) 0.90
Proliferation equivalent of 'accelerated repopulation' in mouse oral mucosa. Int J Radiat Biol (1994) 0.89
Radiation-induced impairment of osseous healing: quantitative studies using a standard drilling defect in rat femur. Radiat Res (1995) 0.89
The radiosensitivity of malignant melanomas part I: experimental studies. Int J Radiat Oncol Biol Phys (1981) 0.87
Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol (1990) 0.87
Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure. Onkologie (2002) 0.85
Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial. Br J Cancer (2013) 0.84
The radiosensitivity of malignant melanomas part II: clinical studies. Int J Radiat Oncol Biol Phys (1981) 0.84
Radiation response of the mouse tongue epithelium. Br J Cancer Suppl (1986) 0.83
Vascular architecture of experimental tumours--influence of tumour volume and transplantation site. Int J Radiat Biol (1991) 0.82
Pharmacokinetics of 5-fluorouracil in patients heterozygous for the IVS14+1G > A mutation in the dihydropyrimidine dehydrogenase gene. Nucleosides Nucleotides Nucleic Acids (2008) 0.82
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study. Br J Cancer (2012) 0.82
[Chemotherapy of bone tumors]. Chirurg (1986) 0.81
Treatment of metastatic sweat gland carcinoma by a four drug combination chemotherapy: response in two cases. Med Oncol Tumor Pharmacother (1986) 0.81
Increased radiation tolerance of mouse tongue epithelium after local conditioning. Int J Radiat Biol (1992) 0.81
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases. Anticancer Res (1999) 0.79
A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Semin Oncol (1992) 0.79
Radiation-induced impairment of bone healing in the rat femur: effects of radiation dose, sequence and interval between surgery and irradiation. Radiother Oncol (1998) 0.79
Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother Oncol (1991) 0.79
Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metastasis (1994) 0.79
[Effect of a combination therapy of cisplatin and local irradiation on a mouse fibrosarcoma]. Strahlentherapie (1985) 0.78
Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line. Eur J Clin Pharmacol (1981) 0.78
Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate. Cancer Chemother Pharmacol (1982) 0.78
Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions. Eur J Med Res (1999) 0.78
Regrowth delay analysis of irradiated tumors in the curative dose region. Int J Radiat Oncol Biol Phys (2000) 0.78
Response of human tumour xenografts to fractionated X-irradiation. Radiother Oncol (1986) 0.77
Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids. Cancer Res (1995) 0.77
The radiosensitivity of recurrent clones of an irradiated murine squamous cell carcinoma in the in vitro megacolony system. Radiother Oncol (1998) 0.77
Capacity and kinetics of SLD repair in mouse tongue epithelium. Radiother Oncol (1993) 0.77
Proliferation kinetics of mouse tongue epithelium under normal conditions and following single dose irradiation. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.77
Erythroid and myeloid maturation patterns related to progenitor assessment in the myelodysplastic syndromes. Br J Haematol (1987) 0.77
Effects of single-dose irradiation on bronchial epithelium: a comparison of BEAS 2B cell monolayers, human organ cultures, and Goettinger minipigs. Radiat Res (2003) 0.77
The proliferative capacity of mouse fibrosarcoma cells that survived x-irradiation. Radiat Environ Biophys (1995) 0.76
[Percutaneous implantation of port-catheter systems for intraarterial chemotherapy of the liver]. Radiologe (1999) 0.76
Effects of stimulated repopulation on oral mucositis during conventional radiotherapy. Radiother Oncol (1995) 0.76
[Tumor markers--how they should be applied]. MMW Fortschr Med (2005) 0.76
[Radiation sensitivity of the amelanotic hamstermelanoma in vitro and in vivo (author's transl)]. Strahlentherapie (1978) 0.75
Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry. Br J Cancer (1993) 0.75
Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume. Radiother Oncol (1994) 0.75
CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer. Anticancer Res (1999) 0.75
[Detection of methotrexate in human serum. Comparison between an enzymatic and an enzyme-immunologic method]. Onkologie (1980) 0.75
Biochemical control of high-dose methotrexate/Leucovorin rescue therapy. Recent Results Cancer Res (1980) 0.75
[Indurating soft tissue swelling, eosinophilia and increased blood sedimentation rate]. Internist (Berl) (1993) 0.75
[High-voltage electrophoresis of dihydrofolate reductase from Escherichia coli W 3110 (author's transl)]. Res Exp Med (Berl) (1977) 0.75
[Combined intraoperative and external irradiation of the celiac artery in the rabbit: the effects on the blood flow of the gastric mucosa]. Strahlenther Onkol (1996) 0.75
[45-year-old patient with extensive distally accentuated polyneuropathy and roentgenologic changes in the left ischium]. Internist (Berl) (1985) 0.75
[A new determination method of dihydrofolate reductase using ( 3 H) dihydrofolic acid]. Hoppe Seylers Z Physiol Chem (1972) 0.75
[Splenomegaly and peripheral pancytopenia in a 62-year-old patient]. Internist (Berl) (1988) 0.75
[Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer]. Fortschr Med (1985) 0.75
[Mediastinal metastasis in osteogenic sarcoma. X-ray and nuclear medicine follow-up]. Rofo (1987) 0.75
The biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate. Eur J Cancer (1979) 0.75
Role of polyglutamates in methotrexate action. Chemioterapia (1985) 0.75
[Electrophoretic separation of isoenzymes of glutathione reductase and pyruvate kinase in human erythrocytes]. Klin Wochenschr (1968) 0.75
[Perfusion scintigraphy using 99mTc-labeled microspheres in the functional evaluation of an implanted portsystem for intraarterial cytostatic treatment of liver metastases]. Nuklearmedizin (1988) 0.75
Purification of dihydrofolate reductase from human leukocytes and from mouse liver and electrofocusing on thin-layer polyacrylamide gel. Enzyme (1980) 0.75
The influence of high-dose methotrexate therapy on serum iron. Klin Wochenschr (1986) 0.75
Biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate treatment: implications for therapy. Recent Results Cancer Res (1978) 0.75
Ferrokinetics after high-dose methotrexate therapy. Klin Wochenschr (1981) 0.75
[Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin]. Onkologie (1980) 0.75
Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy. Klin Wochenschr (1983) 0.75
Should tumors be clamped in radiobiological fractionation experiments? Int J Radiat Oncol Biol Phys (1993) 0.75
[Small cell prostatic carcinoma. Presentation of diagnosis, therapy and prognosis based on a case report]. Fortschr Med (1994) 0.75
[Methotrexate-resistance through gene transfer]. MMW Munch Med Wochenschr (1980) 0.75
[Ineffectiveness of high-dosage methotrexate in patients with small cell bronchial cancer]. Onkologie (1982) 0.75
[Ferrokinetics: principles, results, indications (author's transl)]. Klin Wochenschr (1981) 0.75
Experimental study of vascular sequelae of combined upper abdominal intraoperative and external-beam radiation therapy. Front Radiat Ther Oncol (1997) 0.75
[Function tests in the differential diagnosis of megaloblastic anemias]. Med Welt (1984) 0.75
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy]. Med Klin (Munich) (1994) 0.75
[Malignant primary bone tumors. Diagnosis, therapy and results of treatment]. Fortschr Med (1989) 0.75
[The results of simultaneous radio-chemotherapy in advanced head and neck tumors]. Strahlenther Onkol (1990) 0.75
Differential effect of high-dose methotrexate on erythropoiesis and granulocytopoiesis in humans. Cancer Res (1982) 0.75
[Results of simultaneous radio-polychemotherapy in advanced inoperable cancer of the head and neck]. Laryngol Rhinol Otol (Stuttg) (1988) 0.75
Adjuvant chemotherapy of stage-ii nonseminomatous testicular cancer. Oncol Rep (1994) 0.75
[Drug treatment of bone-marrow insufficiency]. Hamatol Bluttransfus (1975) 0.75
[Bronchial cancer: diagnostic potentials and limits of chemotherapy. 1. Small cell bronchial cancer]. Fortschr Med (1985) 0.75
[A 39-year-old patient with acute onset of fever, myalgia and diarrhea and followed by jaundice]. Internist (Berl) (1989) 0.75
[Septic temperatures and throat pain in a patient with hyperthyroidism]. Internist (Berl) (1990) 0.75
[Inhibition of human leukocytes dihydrofolate reductase by triamterene and its metabolites (author's transl)]. Arzneimittelforschung (1979) 0.75
A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Semin Oncol (1992) 0.75
[Adjuvant chemotherapy of malignant bone tumors]. Langenbecks Arch Chir (1982) 0.75